Olimel 5.7% 1.65 g

OlimeL 5.7% 1.65 G is an intravenous emulsion containing L-aspartic acid. It is used to support metabolic processes and provide essential amino acids for nutritional therapy. This product is manufactured by Baxter Corporation in Canada.

OlimeL 5.7% 1.65 G is primarily used for nutritional support in patients who require intravenous administration of amino acids. L-aspartic acid, the active ingredient, plays a crucial role in various metabolic pathways. This emulsion is often used in clinical settings to support patients who cannot obtain adequate nutrition through oral intake. It is important to consult healthcare professionals to determine the appropriate use of OlimeL 5.7% 1.65 G.

The effects of OlimeL 5.7% 1.65 G are generally related to its role in providing essential amino acids. Patients may experience improved nutritional status and support for metabolic processes. As with any intravenous therapy, individual responses can vary, and it is important to monitor for any adverse reactions.

OlimeL 5.7% 1.65 G should be administered under the supervision of a healthcare professional. It is crucial to follow proper handling and storage guidelines to maintain the integrity of the emulsion. Patients with known allergies to any of the components should avoid using this product. Always consult a healthcare provider before starting any new treatment.

OlimeL 5.7% 1.65 G may interact with other medications or supplements. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Specific interactions with alcohol or other substances should be discussed with a healthcare professional.